$HNGE

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

Original reporting
Published Nov 3, 2026, 4:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Hinge Health (HNGE) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$HNGEBullishHigh
01

Why it matters

The earnings beat and margin expansion could attract growth‑oriented investors, but integration of new programs carries risk.

02

Market read

Strong earnings may boost Hinge Health stock; limited spillover to broader health‑tech sector.

03

What to watch

Execution risk of new Migraine and GI programs and integration costs.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Hinge Health is a digital health company focusing on musculoskeletal, migraine, and gastrointestinal care.

Company-level read

Ticker impact

$HNGEBullishHigh confidence
Context

Q3 2026 earnings call disclosed revenue of $235M (+52% YoY) and operating margin of 33%, a fresh primary earnings report.

Expected impact

likely upward pressure as investors price in robust growth and margin expansion

Evidence & confidence

First‑time disclosure of significantly higher revenue and margins; market may react positively.

Market effects

Highlights growth potential in digital musculoskeletal health and tele‑rehab sector.

U.S. digital health stocks may see modest lift.

Limited to health‑tech niche; no broad market effect.

Counterpoint

Valuation may already price in growth; earnings beat could be already baked in.

Key entities

  • Hinge Health

    Digital health provider reporting Q3 2026 results.

  • Jim Pursley

    President announcing step‑back from role.

Related articles

$HNGEHighAI 8/10

What Hinge Health (HNGE) Said on Its Q3 Earnings Call

Hinge Health (HNGE) raised its full-year 2026 revenue outlook to $879M-$881M and non-GAAP operating income to $266M-$268M. Q4 revenue is expected at $249M-$251M, up 46% YoY. The company added 3,270 clients, up 28% YoY, and expanded its product offerings. President Jim Pursley will step down at year-end.

$HNGEHighAI 8/10

Hinge Health reports record third quarter 2026 financial results

Hinge Health, Inc. (HNGE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Hinge Health reports record third quarter 2026 financial results • Revenue increased 52% year-over-year to $235 million • Free cash flow of $113 million, representing a 48% free cash flow margin • 2026 revenue guidance midpoint raised to $880 million, reflecting 50%